Carmichael Hill & Associates, Inc. Contrafect Corp Transaction History

Carmichael Hill & Associates, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	BUY	$3.58 - $4.9 $179 - $245	50 Added 100.0%	100 $0
Q1 2021 Apr 28, 2021	SELL	$4.46 - $6.68 $401 - $601	-90 Reduced 64.29%	50 $0
Q3 2020 Nov 12, 2020	BUY	$5.05 - $6.99 $252 - $349	50 Added 55.56%	140 $1,000
Q2 2020 Aug 05, 2020	BUY	$4.69 - $7.81 $422 - $702	90 New	90 $1,000

49.2K

Ticker CFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,332,700
Market Cap $1.18M
Description
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.